ClinicalTrials.gg
Sign In

Drug

HRS-5041 clinical trials

Also written HRS-5041.

studies test it
7
open now
4
in phase 3
0
first study started
2023

Keep track of what changes. Save the HRS-5041 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

HRS-5041 Tablets
2

Development codes

HRS-5041
3

Studies by the year they started

7 studies that test it; most in 2024 (3)

Studies that test HRS-5041, by start year
YearStudies
20231
20243
20253

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Prostatic Neoplasms
4

Who runs them

Industry 6 · Other 1

Jiangsu HengRui Medicine Co., Ltd. (3) · Atridia Pty Ltd. (2) · Fudan University (1) · Hansoh BioMedical R&D Company (1)

Often tested with

Tested in the same studies.

Rifampin (1) · HRS-2189 (1) · Prednisone acetate (1) · Prednisone (1) · HRS-6208 (1) · Risvutatug rezetecan (1)

Studies

Open first, then newest update. How each study uses HRS-5041 is read from its arms, and is right about nine times in ten.

Testing it · 7

Given in every arm · 1 — HRS-5041 is usual care beside what is tested